Skip to content
value.today

ViaCyte Inc.

Total raised
$150 M
5 rounds on record
Latest round
$54 M
Apr 2021
First round on record
Jul 2013
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of ViaCyte Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2021$54 MNo. 5$50 to $250 million

ViaCyte Inc.: Raise no. 5, Apr 2021

Investors in this round

22 investors had bought by the notice of Apr 22, 2021: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$54 M of $59 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anne G. Sandan · Executive Officer
  • Brittany G. Bradrick · Executive Officer
  • Elizabeth G. Bui · Executive Officer
  • Howard G. Foyt · Executive Officer
  • Kevin G. D'Amour · Executive Officer
  • Michael Yang · Executive Officer, Director
  • Steve G. White · Executive Officer
  • Amir R. Zamani · Director
  • Asish R. Xavier · Director
  • Fred A. Middleton · Director
  • Ian G. Smith · Director
  • Lucian A. Iancovici · Director
  • Mark G. Foletta · Director
  • Paul G. Hastings · Director
  • Sandra G. Poole · Director
  • Steven R. Altman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness.”

Signed by Anne Sandan, Vice President, Finance, Corporate Controller & Secretary. Source: SEC Form D, newest notice filed Apr 22, 2021. Read the notice at the SEC.

equitySEC
Mar 2020$33 MNo. 4$10 to $50 million

ViaCyte Inc.: Raise no. 4, Mar 2020

Investors in this round

17 investors had bought by the notice of Apr 2, 2020: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$33 M of $36 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anne G. Sandan · Executive Officer
  • Howard G. Foyt · Executive Officer
  • Kevin G. D'Amour · Executive Officer
  • Liz G. Bui · Executive Officer
  • Mark G. Zimmerman · Executive Officer
  • Paul Laikind · Executive Officer, Director
  • Steve G. Kradjian · Executive Officer
  • Adam R. Koppel · Director
  • Asish R. Xavier · Director
  • Fred A. Middleton · Director
  • Heath A. Lukatch · Director
  • Ian G. Smith · Director
  • Mark G. Foletta · Director
  • Paul G. Hastings · Director
  • Sandra G. Poole · Director
  • Steven R. Altman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness.”

Signed by Anne Sandan, Vice President, Finance, Corporate Controller & Secretary. Source: SEC Form D, newest notice filed Apr 2, 2020. Read the notice at the SEC.

equitySEC
Nov 2018$36 MNo. 3$10 to $50 million

ViaCyte Inc.: Raise no. 3, Nov 2018

Investors in this round

9 investors had bought by the notice of Dec 3, 2018: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$36 M of $90 M offered; $54 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$2,743,800
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anne G. Sandan · Executive Officer
  • Elizabeth G. Bui · Executive Officer
  • Howard G. Foyt · Executive Officer
  • Kevin G. D'Amour · Executive Officer
  • Paul Laikind · Executive Officer, Director
  • Adam R. Koppel · Director
  • Asish R. Xavier · Director
  • Fred A. Middleton · Director
  • Heath A. Lukatch · Director
  • Mark G. Foletta · Director
  • Steven R. Altman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Raymond James & Associates, Inc. (CRD 705) · St. Petersburg, FloridaSold in all US states

Remarks in the notice

  • On fees: “Represents an estimate of fees that may be paid by the Company to a placement agent upon receipt of the total offering amount listed in Section 13 herein.”
  • On the amounts: “Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness.”

Signed by Anne Sandan, Vice President, Finance, Corporate Controller & Secretary. Source: SEC Form D, newest notice filed Dec 3, 2018. Read the notice at the SEC.

equitySEC
Aug 2014$15 MNo. 2$10 to $50 million

ViaCyte Inc.: Raise no. 2, Aug 2014

Investors in this round

1 investor had bought by the notice of Aug 21, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Securities offered consist of a convertible promissory note and the shares of preferred or common stock issuable upon the conversion thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allan G. Robins · Executive Officer
  • Anne G. Sandan · Executive Officer
  • Elizabeth G. Bui · Executive Officer
  • Howard G. Foyt · Executive Officer
  • Kevin G. D'Amour · Executive Officer
  • Michael G. Scott · Executive Officer
  • Paul Laikind · Executive Officer, Director
  • Donald J. Elmer · Director
  • Franklin P. Johnson · Director
  • Fred A. Middleton · Director
  • Mark G. Foletta · Director
  • Orville G. Kolterman · Director
  • Steven R. Altman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anne Sandan, Sr. Director, Finance, Controller & Secretary. Source: SEC Form D, newest notice filed Aug 21, 2014. Read the notice at the SEC.

debt, optionsSEC
Jul 2013$12 MNo. 1$10 to $50 million

ViaCyte Inc.: Raise no. 1, Jul 2013

Investors in this round

55 investors had bought by the notice of Jul 19, 2013: 55 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $27 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Securities offered consist of convertible preferred stock, warrants exercisable for shares of convertible preferred stock and common stock and the underlying preferred and common stock issuable upon t
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allan K. Robin · Executive Officer
  • Anne K. Sandan · Executive Officer
  • Howard K. Foyt · Executive Officer
  • Kevin K. D'Amour · Executive Officer
  • Liz K. Bui · Executive Officer
  • Michael K. Scott · Executive Officer
  • Paul Laikind · Executive Officer, Director
  • Asish K. Xavier · Director
  • Donald J. Elmer · Director
  • Franklin P. Johnson · Director
  • Fred A. Middleton · Director
  • Orville G. Kolterman · Director
  • Steven R. Altman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amounts listed include the following amounts receivable by the Issuer upon exercise of common stock warrants and preferred stock warrants: subsection (a) - $2,175,642; subsection (b) - $1,528,637. Such warrants have not been exercised.”

Signed by Anne Sandan, Sr. Director, Finance, Controller & Secretary. Source: SEC Form D, newest notice filed Jul 19, 2013. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • ViaCyte Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2021).

    SEC Form D · Apr 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2021

That is all the official record says: ViaCyte Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of ViaCyte Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 55 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by ViaCyte Inc.
NameRoleNamed in
Anne G. SandanExecutive officerApr 2021
Brittany G. BradrickExecutive officerApr 2021
Elizabeth G. BuiExecutive officerApr 2021
Howard G. FoytExecutive officerApr 2021
Kevin G. D'AmourExecutive officerApr 2021
Michael YangExecutive officerApr 2021
Steve G. WhiteExecutive officerApr 2021
Liz G. BuiExecutive officerApr 2020
Mark G. ZimmermanExecutive officerApr 2020
Paul LaikindExecutive officerApr 2020
Steve G. KradjianExecutive officerApr 2020
Allan G. RobinsExecutive officerAug 2014
Michael G. ScottExecutive officerAug 2014
Allan K. RobinExecutive officerJul 2013
Anne K. SandanExecutive officerJul 2013
Howard K. FoytExecutive officerJul 2013
Kevin K. D'AmourExecutive officerJul 2013
Liz K. BuiExecutive officerJul 2013
Michael K. ScottExecutive officerJul 2013
Amir R. ZamaniDirectorApr 2021
Asish R. XavierDirectorApr 2021
Fred A. MiddletonDirectorApr 2021
Ian G. SmithDirectorApr 2021
Lucian A. IancoviciDirectorApr 2021
Mark G. FolettaDirectorApr 2021
Michael YangDirectorApr 2021
Paul G. HastingsDirectorApr 2021
Sandra G. PooleDirectorApr 2021
Steven R. AltmanDirectorApr 2021
Adam R. KoppelDirectorApr 2020
Heath A. LukatchDirectorApr 2020
Paul LaikindDirectorApr 2020
Donald J. ElmerDirectorAug 2014
Franklin P. JohnsonDirectorAug 2014
Orville G. KoltermanDirectorAug 2014
Asish K. XavierDirectorJul 2013

About

Company in San Diego, United States.